Open-label Early Phase 2 Study With a Single Arm of Interferon Gamma-1b Treatment of Osteopetrosis

Trial Profile

Open-label Early Phase 2 Study With a Single Arm of Interferon Gamma-1b Treatment of Osteopetrosis

Recruiting
Phase of Trial: Phase II

Latest Information Update: 07 May 2017

At a glance

  • Drugs Interferon gamma-1b (Primary)
  • Indications Osteopetrosis
  • Focus Adverse reactions
  • Most Recent Events

    • 09 Mar 2016 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
    • 11 Feb 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top